AKT1 and neoplasm: The reduced p-Akt levels, confirmed by both IHC (Figure 5E) and Western blot (Figure 5F) analyses, indicate the effective suppression of the PI3K/AKT signaling pathway in the tumor xenografts treated with LK-A.